Overexpression of PSMC2 promotes the tumorigenesis and development of human breast cancer via regulating plasminogen activator urokinase (PLAU)
Abstract Emerging evidence has declared that Proteasome 26S subunit ATPase 2 (PSMC2) is involved in tumor progression. However, its role in breast cancer has not been investigated. Therefore, we sought to establish a correlation between breast cancer and PSMC2. PSMC2 expression in tissues was detect...
Main Authors: | Yanyan Wang, Mingzhi Zhu, Jingruo Li, Youyi Xiong, Jing Wang, Haihong Jing, Yuanting Gu |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Publishing Group
2021-07-01
|
Series: | Cell Death and Disease |
Online Access: | https://doi.org/10.1038/s41419-021-03960-w |
Similar Items
-
Neuroprotection by urokinase plasminogen activator in the hippocampus
by: Eunsil Cho, et al.
Published: (2012-04-01) -
Regulation of urokinase plasminogen activator in the gastric epithelium
by: Duval, CeÌdric
Published: (2007) -
Evaluation of Urokinase Plasminogen Activator Receptor, Soluble Urokinase Plasminogen Activator Receptor, and β1 Integrin in Patients with Hodgkin′s Lymphoma
by: Shirin Kouhpayeh, et al.
Published: (2017-01-01) -
The urokinase-type plasminogen activator polymorphism PLAU_1 is a risk factor for APOE-ε4 non-carriers in the Italian Alzheimer’s disease population and does not affect the plasma Aβ(1–42) level
by: Marzia Pesaresi, et al.
Published: (2007-03-01) -
Urokinase-type plasminogen activator promotes synaptic repair in the ischemic brain
by: Ariel Diaz, et al.
Published: (2018-01-01)